- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Portable MR system aids diagnosis of rheumatic diseases
GE Medical Systems Lunar introduced the Applause, a portable MR device, at the RSNA meeting. The system is optimized for diagnosing early signs of joint erosion due to rheumatoid arthritis and other forms of autoimmune rheumatoid diseases.
GE Medical Systems Lunar introduced the Applause, a portable MR device, at the RSNA meeting. The system is optimized for diagnosing early signs of joint erosion due to rheumatoid arthritis and other forms of autoimmune rheumatoid diseases.
Images obtained with the Applause may also be used to determine the severity of disease and to monitor its progression and treatment. The system's easy portability allows transport among rooms in private-practice offices, hospitals, or clinics.
The scanner, developed by MagneVu in Carlsbad, CA, is being distributed under agreement with GE. It was first unveiled in October at the annual meeting of the American College of Rheumatology.
The Applause uses a nonhomogeneous magnetic field to image the hand, wrist, and foot. MR promises earlier detection of arthritis, potentially leading to more effective treatment of the disease, according to MagneVu. The compact, portable magnet can be rolled into any exam room. It requires no special office setup or shielding and can be plugged into a wall outlet. The unit obtains and displays images in all three planes of view and provides scans that are similar in clarity to conventional MR images, according to GE.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
